Close

Rating History for Summit Therapeutics plc (SMMT) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2020 N/A Downgrade Neutral
(Buy)
N/A
(N/A)
4.58
(3.50)
-23.58% Details